The weekly litigation news digest is live. Subscribe now

IP Verse

Claudin-18.2-Specific Immunoreceptors And T Cell Epitopes - EP3294333

The patent EP3294333 was granted to Biontech Cell&Gene Therapies on Jul 9, 2025. The application was filed on May 9, 2016 under application number EP16721176A. The patent is currently recorded with a legal status of "Patent Maintained As Amended".

EP3294333

BIONTECH CELL&GENE THERAPIES
Application Number
EP16721176A
Filing Date
May 9, 2016
Status
Patent Maintained As Amended
Feb 14, 2025
Publication Date
Jul 9, 2025
External Links
Slate, Register, Google Patents

Patent Summary

Patent Family

Patent Family

Patent Oppositions (2)

Patent oppositions filed by competitors challenge the validity of a granted patent. These oppositions are typically based on claims of prior art, lack of novelty, or non-obviousness. They are a key part of the process for determining a patent's strength and enforceability.

CompanyOpposition DateRepresentativeOpposition Status
DR H ULRICH DORRIESMay 31, 2021DORRIESADMISSIBLE
DR H ULRICH DORRIESMay 31, 2021DORRIES, HANS ULRICH , DF-MP DORRIES FRANK-MOLNIA & POHLMANADMISSIBLE

Patent Citations (13) New

Patent citations refer to prior patents cited during different phases such as opposition or international search.

Citation PhasePublication Number
DESCRIPTIONUS2003118592
DESCRIPTIONUS2003133939
DESCRIPTIONWO9633265
DESCRIPTIONWO9724447
INTERNATIONAL-SEARCH-REPORTWO2005113587
INTERNATIONAL-SEARCH-REPORTWO2008145338
INTERNATIONAL-SEARCH-REPORTWO2012038055
INTERNATIONAL-SEARCH-REPORTWO2014146672
OPPOSITIONEP2016060337W
OPPOSITIONEP3126381
OPPOSITIONWO2005113587
OPPOSITIONWO2012038055
OPPOSITIONWO2014146672

Dossier Documents

The dossier documents provide a comprehensive record of the patent's prosecution history - including filings, correspondence, and decisions made by patent offices - and are crucial for understanding the patent's legal journey and any challenges it may have faced during examination.

  • Date

    Description

  • Get instant alerts for new documents